These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 17974293

  • 1. Managing the neuropsychiatric complications of hepatitis C treatment.
    Sockalingam S, Shammi C, Stergiopoulos V.
    Br J Hosp Med (Lond); 2007 Oct; 68(10):520-5. PubMed ID: 17974293
    [Abstract] [Full Text] [Related]

  • 2. Mania during treatment of chronic hepatitis C with pegylated interferon and ribavirin.
    Onyike CU, Bonner JO, Lyketsos CG, Treisman GJ.
    Am J Psychiatry; 2004 Mar; 161(3):429-35. PubMed ID: 14992966
    [No Abstract] [Full Text] [Related]

  • 3. Hepatitis C treatment in patients with drug addiction: clinical management of interferon-alpha-associated psychiatric side effects.
    Schaefer M, Mauss S.
    Curr Drug Abuse Rev; 2008 Jun; 1(2):177-87. PubMed ID: 19630716
    [Abstract] [Full Text] [Related]

  • 4. Interferon for hepatitis C patients with psychiatric disorders.
    Wilson MS.
    Am J Psychiatry; 2004 Dec; 161(12):2332; author reply 2332-4. PubMed ID: 15569921
    [No Abstract] [Full Text] [Related]

  • 5. Managing the neuropsychiatric side effects of interferon-based therapy for hepatitis C.
    Crone CC, Gabriel GM, Wise TN.
    Cleve Clin J Med; 2004 May; 71 Suppl 3():S27-32. PubMed ID: 15468615
    [Abstract] [Full Text] [Related]

  • 6. Psychiatric symptoms induced by antiviral therapy in chronic hepatitis C: comparison between interferon-alpha-2a and interferon-alpha-2b.
    Neri S, Pulvirenti D, Bertino G.
    Clin Drug Investig; 2006 May; 26(11):655-62. PubMed ID: 17163300
    [Abstract] [Full Text] [Related]

  • 7. Psychiatric care during hepatitis C treatment: the changing role of psychiatrists in the era of direct-acting antivirals.
    Sockalingam S, Sheehan K, Feld JJ, Shah H.
    Am J Psychiatry; 2015 Jun; 172(6):512-6. PubMed ID: 26029803
    [No Abstract] [Full Text] [Related]

  • 8. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].
    Vignau J, Costisella O, Canva V, Imbenotte M, Duhamel A, Lhermitte M.
    Encephale; 2009 Oct; 35(5):477-83. PubMed ID: 19853722
    [Abstract] [Full Text] [Related]

  • 9. Incidence of psychiatric side effects during pegylated interferon- alpha retreatment in nonresponder hepatitis C virus-infected patients.
    Quarantini LC, Bressan RA, Galvão A, Batista-Neves S, Paraná R, Miranda-Scippa A.
    Liver Int; 2007 Oct; 27(8):1098-102. PubMed ID: 17845538
    [Abstract] [Full Text] [Related]

  • 10. Psychosis during peginterferon-alpha 2a and ribavirin therapy: case report.
    Quarantini LC, Cruz SC, Batista-Neves SC, Paraná R, Miranda-Scippa A, Bressan RA.
    Braz J Infect Dis; 2006 Dec; 10(6):406-7. PubMed ID: 17420915
    [Abstract] [Full Text] [Related]

  • 11. Interferon for hepatitis C patients with psychiatric disorders.
    Asnis GM, De La Garza R, Rego SA, Henderson MA, Reinus JF.
    Am J Psychiatry; 2004 Dec; 161(12):2332; author reply 2332-4. PubMed ID: 15569920
    [No Abstract] [Full Text] [Related]

  • 12. Psychiatric management of HIV/HCV-coinfected patients beginning treatment for hepatitis C virus infection: survey of provider practices.
    Weiss JJ, Morgello S.
    Gen Hosp Psychiatry; 2009 Dec; 31(6):531-7. PubMed ID: 19892211
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects.
    Schaefer M, Hinzpeter A, Mohmand A, Janssen G, Pich M, Schwaiger M, Sarkar R, Friebe A, Heinz A, Kluschke M, Ziemer M, Gutsche J, Weich V, Halangk J, Berg T.
    Hepatology; 2007 Oct; 46(4):991-8. PubMed ID: 17668880
    [Abstract] [Full Text] [Related]

  • 14. An interferon-alpha-induced psychotic disorder in a patient with chronic hepatitis C.
    Bozikas V, Petrikis P, Balla A, Karavatos A.
    Eur Psychiatry; 2001 Mar; 16(2):136-7. PubMed ID: 11311181
    [No Abstract] [Full Text] [Related]

  • 15. Depression and hepatitis C.
    Sangwaiya A, Chan J, Ash S.
    Br J Hosp Med (Lond); 2007 Dec; 68(12):682. PubMed ID: 18186414
    [No Abstract] [Full Text] [Related]

  • 16. Interferon for hepatitis C patients with psychiatric disorders.
    Rifai MA, Bozorg B, Rosenstein DL.
    Am J Psychiatry; 2004 Dec; 161(12):2331-2; author reply 2332-4. PubMed ID: 15569919
    [No Abstract] [Full Text] [Related]

  • 17. The management of side-effects during therapy for hepatitis C.
    Aspinall RJ, Pockros PJ.
    Aliment Pharmacol Ther; 2004 Nov 01; 20(9):917-29. PubMed ID: 15521838
    [Abstract] [Full Text] [Related]

  • 18. Cognition in hepatitis C patients treated with pegylated interferon.
    Wobrock T, Mihm U, Löhr C, Hofmann WP, Sarrazin C, Zeuzem S, Falkai P.
    World J Biol Psychiatry; 2009 Nov 01; 10(4 Pt 3):819-26. PubMed ID: 19995219
    [Abstract] [Full Text] [Related]

  • 19. The successful use of electroconvulsive therapy in a patient with interferon-induced psychotic depression.
    Zincke MT, Kurani A, Istafanous R, Kellner C.
    J ECT; 2007 Dec 01; 23(4):291-2. PubMed ID: 18090708
    [Abstract] [Full Text] [Related]

  • 20. Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review.
    Dieperink E, Willenbring M, Ho SB.
    Am J Psychiatry; 2000 Jun 01; 157(6):867-76. PubMed ID: 10831463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.